Research Paper Volume 15, Issue 23 pp 13776—13798

Figure 6. Immune subtypes, treatment response, and gene ontology (GO) analysis in high and low-risk groups. (A) Differences in risk scores among C1, C2, and C4 immune subtypes. (B) Sankey plot showing high and low expression trends of different clinical features of C1, C2, and C4 subtypes in samples of patients with ovarian cancer. (C) Comparison of risk scores in treatment response (Well vs. Poor) and recurrence (Recurrence vs. Non-Recurrence). (D) Drug sensitivity analysis for LCL161, ribociclib, and topotecan treatments in ovarian cancer. (E) GO analysis in high and low-risk groups. (F) Correlations between tumor immunity and ovarian cancer using data from various databases.